Burzynski Research Institute Inc

BZYR | Healthcare | OTC
$0.02
-0.01 (-38.24%)

Key Metrics

Market Cap
$2.76M
P/E Ratio
-2.10
EPS
$-0.01
Beta
N/A
Dividend Yield
N/A
ROE
2,073.54%
Current Ratio
0.03

Company Information

Industry
Biotechnology

About Burzynski Research Institute Inc

Burzynski Research Institute Inc engages in the research and development of antineoplaston drugs to treat cancer The company is also involved in the production marketing promotion and sale of medical chemical compounds composed of growthinhibiting peptides amino acid derivatives and organic acids under the Antineoplastons trade name It also offers consulting services Burzynski Research Institute Inc was founded in 1977 and is based in Houston Texas

Financial Ratios (TTM)

Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
0.00%
ROA
-56,820.20%
Price to Book
-66.37
Price to Sales
0.00